Soria JC - Search Results

1

No evidence for viral sequences in five lepidic adenocarcinomas (former "BAC") by a high-throughput sequencing approach.

Berthet N, Frangeul L, Olaussen KA, Brambilla E, Dorvault N, Girard P, Validire P, Fadel E, Bouchier C, Gessain A, Soria JC. Berthet N, et al. Among authors: soria jc. BMC Res Notes. 2015 Dec 15;8:782. doi: 10.1186/s13104-015-1669-8. BMC Res Notes. 2015. PMID: 26667652 Free PMC article.

2

Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.

Planchard D, Soria JC, Michiels S, Grunenwald D, Validire P, Caliandro R, Girard P, Le Chevalier T. Planchard D, et al. Among authors: soria jc. Cancer. 2004 Jan 1;100(1):28-35. doi: 10.1002/cncr.11881. Cancer. 2004. PMID: 14692021 Free article.

3

Loss of PTEN expression is not uncommon, but lacks prognostic value in stage I NSCLC.

Olaussen KA, Soria JC, Morat L, Martin A, Sabatier L, Morere JF, Khayat D, Spano JP. Olaussen KA, et al. Among authors: soria jc. Anticancer Res. 2003 Nov-Dec;23(6C):4885-90. Anticancer Res. 2003. PMID: 14981940

4

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.

Lantuejoul S, Soria JC, Moro-Sibilot D, Morat L, Veyrenc S, Lorimier P, Brichon PY, Sabatier L, Brambilla C, Brambilla E. Lantuejoul S, et al. Among authors: soria jc. Br J Cancer. 2004 Mar 22;90(6):1222-9. doi: 10.1038/sj.bjc.6601643. Br J Cancer. 2004. PMID: 15026805 Free PMC article.

5

Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.

Erman M, Grunenwald D, Penault-Llorca F, Grenier J, Besse B, Validire P, Morat L, Girard P, Le Chevalier T, Sabatier L, Soria JC. Erman M, et al. Among authors: soria jc. Lung Cancer. 2005 Mar;47(3):315-23. doi: 10.1016/j.lungcan.2004.08.015. Lung Cancer. 2005. PMID: 15713515

6

Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.

Lantuejoul S, Soria JC, Morat L, Lorimier P, Moro-Sibilot D, Sabatier L, Brambilla C, Brambilla E. Lantuejoul S, et al. Among authors: soria jc. Clin Cancer Res. 2005 Mar 1;11(5):2074-82. doi: 10.1158/1078-0432.CCR-04-1376. Clin Cancer Res. 2005. PMID: 15756034

7

Cyclooxygenase-2 as a target for anticancer drug development.

Méric JB, Rottey S, Olaussen K, Soria JC, Khayat D, Rixe O, Spano JP. Méric JB, et al. Among authors: soria jc. Crit Rev Oncol Hematol. 2006 Jul;59(1):51-64. doi: 10.1016/j.critrevonc.2006.01.003. Epub 2006 Mar 13. Crit Rev Oncol Hematol. 2006. PMID: 16531064 Review.

8

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Olaussen KA, Dunant A, Fouret P, Brambilla E, André F, Haddad V, Taranchon E, Filipits M, Pirker R, Popper HH, Stahel R, Sabatier L, Pignon JP, Tursz T, Le Chevalier T, Soria JC; IALT Bio Investigators. Olaussen KA, et al. Among authors: soria jc. N Engl J Med. 2006 Sep 7;355(10):983-91. doi: 10.1056/NEJMoa060570. N Engl J Med. 2006. PMID: 16957145 Free article. Clinical Trial.

9

Telomerase expression in lung preneoplasia and neoplasia.

Lantuéjoul S, Salon C, Soria JC, Brambilla E. Lantuéjoul S, et al. Among authors: soria jc. Int J Cancer. 2007 May 1;120(9):1835-41. doi: 10.1002/ijc.22473. Int J Cancer. 2007. PMID: 17311257 Free article. Review.

10

ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer.

Olaussen KA, Mountzios G, Soria JC. Olaussen KA, et al. Among authors: soria jc. Curr Opin Pulm Med. 2007 Jul;13(4):284-9. doi: 10.1097/MCP.0b013e32816b5c63. Curr Opin Pulm Med. 2007. PMID: 17534174 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

732 results

Search Page